Table 4.
The factors affecting the time of TXA treatment.
| TXA <1 h | TXA 1–3 h | p | |
|---|---|---|---|
| Age (years) | 45.00 (25.75–66.00) | 42.00 (33.00–66.50) | 0.970 |
| Female (n (%)) | 6 (23.1%) | 7 (28.0%) | 0.687∗ |
| MAP (mmHg) | 73.33 (63.33–90.83) | 90.00 (75.00–95.00) | 0.022 |
| Pulse (bpm) | 100.00 (90.00–110.00) | 90.00 (79.00–102.50) | 0.030 |
| Saturation (%) | 92.50 (90.00–95.25) | 95.00 (91.50–97.50) | 0.067 |
| GKS | 12.00 (7.00–14.25) | 12.00 (8.50–15.00) | 0.871 |
| pH | 7.356 (7.275–7.391) | 7.365 (7.318–7.405) | 0.361 |
| Lactate (mmol/L) | 3.70 (2.40–4.90) | 3.90 (2.25–5.10) | 0.977 |
| Base deficit (mmol/L) | −5.10 (−8.13–−2.82) | −3.50 (−6.35–−1.75) | 0.184 |
∗Pearson chi-square. p < 0.05 is statistically significant.